Harvard Enters into Deal with Johnson & Johnson Subsidiary

On July 10th it was announced that MBBP client Harvard University, has entered into an agreement with Johnson & Johnson subsidiary Janssen Pharmaceuticals and Evotec, a German biotechnology company. The deal is an expansion of an existing partnership between Evotec and the Harvard lab of Douglas Melton known as the CureBeta research and development program, created …

Continue reading Harvard Enters into Deal with Johnson & Johnson Subsidiary